Integrin αvβ3 and phospholipase C regulate prostacyclin formation of endothelial cells caused by ancrod-generated fibrin

European Journal of Pharmacology

Volumn 297, Issue 1-2, 1996, Pages 129-136

  Chang, Mei C ^a   Yang, Rong S ^a   Lin, Chao H ^a   Huang, Tur F ^a  

^a NATIONAL TAIWAN UNIVERSITY   (Taiwan)

Author keywords

Ancrod generated fibrin; Integrin v 3; Pertussis toxin; Phospholipase C; Prostacyclin

Indexed keywords

3,4,5 TRIMETHOXYBENZOIC ACID 8 (DIETHYLAMINO)OCTYL ESTER; 6 OXOPROSTAGLANDIN F1 ALPHA; ANCROD; CALCIUM; EGTAZIC ACID; ETHYLENE GLYCOL 1,2 BIS(2 AMINOPHENYL) ETHER N,N,N',N' TETRAACETIC ACID; FIBRIN; GLYCYLPROLYLARGINYLPROLINE; GUANINE NUCLEOTIDE BINDING PROTEIN; INOSITOL PHOSPHATE; INTEGRIN; MONOCLONAL ANTIBODY; NEOMYCIN; PERTUSSIS TOXIN; PHOSPHOLIPASE C; PROSTACYCLIN; RADIOISOTOPE; UNCLASSIFIED DRUG;

ARTICLE; CELL CULTURE; CONTROLLED STUDY; DRUG MECHANISM; ENDOTHELIUM CELL; HUMAN; HUMAN CELL; PHOSPHOINOSITIDE METABOLISM; PRIORITY JOURNAL; PROSTAGLANDIN SYNTHESIS; REGULATORY MECHANISM; UMBILICAL VEIN;

6-KETOPROSTAGLANDIN F1 ALPHA; AMINO ACID SEQUENCE; ANCROD; ANTIBODIES, MONOCLONAL; CALCIUM CHANNEL BLOCKERS; CELL ADHESION; CELLS, CULTURED; CULTURE MEDIA; EGTAZIC ACID; ENDOTHELIUM, VASCULAR; EPOPROSTENOL; FIBRIN; FIBRINOLYTIC AGENTS; GALLIC ACID; HUMANS; INOSITOL PHOSPHATES; INTEGRIN ALPHA3BETA1; INTEGRINS; MOLECULAR SEQUENCE DATA; NEOMYCIN; PERTUSSIS TOXIN; PHOSPHOLIPASE C; PROTEIN SYNTHESIS INHIBITORS; VIRULENCE FACTORS, BORDETELLA;

EID: 0030044233     PISSN: 00142999     EISSN: None     Source Type: Journal    
DOI: 10.1016/0014-2999(95)00735-0     Document Type: Article

References (46)

1. Asch, A.S., B. Adelman, M. Fujimoto and R.L. Nachman, 1988, Identification and isolation of a platelet GP Ib-like protein in human umbilical vein endothelial cells and bovine aortic endothelial cells, J. Clin. Invest. 81, 1600.
2. Au, L.C., S.B. Lin, J.S. Chou, G.W. Teh, K.J. Chang and C.C. Shih, 1993, Molecular cloning and sequence analysis of the cDNA for ancrod, a thrombin-like enzyme from the venom of Calloselasma rhodostoma, Biochem. J. 294, 387.
3. Barlow, G.H., W.H. Holleman and L. Lorand, 1970, The action of Arvin on fibrin stabilizing factor (factor XIII), Res. Commun. Chem. Pathol. Pharmacol. I, 9.
4. Bell, W.R., 1988, Clinical trials with ancrod, in: Hemostasis and Animal Venoms, eds. H. Pirkle and F.S. Markland (Marcel Dekkler, New York) p. 541.
5. Brock, T.A. and E. Capasso, 1988, Thrombin and histamine activate phospholipase C in human endothelial cells via a phorbol ester-sensitive pathway, J. Cell Physiol. 36, 54.
6. Camussi, G., E. Turello, F. Bussolino and C. Baglioni, 1991, Tumor necrosis factor alters cytoskeletal organization and barrier function of endothelial cells, Int. Arch. Allergy Appl. Immunol. 96, 84.
7. Carney, D.H., D.L. Scott, E.A. Gordon and E.F. Labelle, 1985, Phosphoinositides in mitogenesis: Neomycin inhibits thrombin-stimulated phosphoinositide turnover and initiation of cell proliferation, Cell 42, 479.
8. Cavender, D.E., 1991, Interations between endothelial cells and the cells of the immune system, Int. Rev. Exp. Pathol. 32, 57.
9. 2: function and pharmacological regulation, Biochem. Pharmacol. 36, 2429.
10. Chang, M.C. and T.F. Huang, 1995, The antiplatelet activity of ancrod upon administration to rabbits, J. Lab. Clin. Med. 125, 508.
11. Chang, M.C., C.Y. Wang and T.F. Huang, 1994, Ancrod-formed fibrin stimulates prostacyclin production of human umbilical vein endothelial cells via de novo synthesis of cyclooxygenase, Biochem. Biophys. Res. Commun. 203, 1920.
12. 3 integrin binding and the subsequent activation of a G-protein coupled phospholipase C, Biochim. Biophys. Acta 1269, 115.
13. Chang, M.C., B.R. Wang and T.F. Huang, 1995b, Characterization of endothelial cell differential attachment to fibrin and fibrinogen and its inhibition by Arg-Gly-Asp-containing peptides, Thromb. Haemostasis 74, 764.
14. 2+ antagonist, 8-(N,N-diethylamino)octyl-3,4,5-trimethoxybenzoate hydrochloride in smooth and skeletal muscles, Br. J. Pharmacol. 53, 279.
15. Criscuolo, G.R., P.I. Lelkes, D. Rotrosen and E.H. Oldfield, 1989, Cytosolic calcium changes in endothelial cells induced by a protein product of human gliomas containing vascular permeability factor activity, J. Neurosurg. 71, 884.
16. Demichele, M.A. and F.L. Minner, 1992, Modulation of vascular endothelial permeability by thrombin, Semin. Thromb. Haemostas. 18, 287.
17. Ewart, M.R., M.W.C. Hatton, J.M. Basford and K.S. Dodgson, 1970, The proteolytic action of Arvin on human fibrinogen, Biochem. J. 118, 603.
18. Galdal, K.S., S.A. Evensen and F. Brosstad, 1982, Effects of thrombin on the integrity of monolayers of cultured human endothelial cells, Thromb. Res. 27, 575.
19. Gelehrter, T.D. and R. Sznycer-Laszuk, 1986, Thrombin induction of plasminogen activator-inhibitor in cultured human endothelial cells, J. Clin. Invest. 77, 165.
20. Gottlieb, A.I., B.L. Langille, M.K.K. Wong and D.W. Kim, 1991, Biology of disease: structure and function of the endothelial cytoskeletion, Lab. Invest. 65, 123.
21. Grossi, I.M., J.S. Hatfield, L.A. Fitzgerald, M. Newcome, J.D. Taylor and K.V. Honn, 1988, Role of tumor cell glycoproteins immunologically related to glycoprotein Ib and IIb/IIIa in tumor cell-platelet and tumor cell-matrix interactions, FASEB J. 2, 2385.
22. Hallam, T.J., J.D. Pearson and L.A. Needham, 1988, Thrombin-stimulated elevation of human endothelial-cell cytoplasmic free calcium concentration causes prostacyclin production, Biochem. J. 251, 243.
23. Henrich, W.L., 1991, The endothelium: a key regulator of vascular tone, Am. J. Med. Sci. 302, 319.
24. Himmel, H.M., A.R. Whortor and H.C. Strauss, 1993, Intracellular calcium, currents, and stimulus-response coupling in endothelial cells, Hypertension 21, 112.
25. Jaffe, E.A., R.L. Nachman, C.G. Becker and C.R. Minick, 1973, Culture of human endothelial cells derived from umbilical veins, J. Clin. Invest. 52, 2745.
26. Jaffe, E.A., J. Grulich, B.B. Weksler, G. Hample and K. Watanabe, 1987, Correlation between thrombin-induced prostacyclin production and inositol trisphosphate and cytosolic calcium levles in cultured human endothelial cells, J. Biol. Chem. 262, 8557.
27. Kaplan, K.L., T. Mather, L. Demarco and S. Solomon, 1989, Effect of fibrin on endothelial cell production of prostacyclin and tissue plasminogen activator, Arteriosclerosis 9, 43.
28. Lattallo, Z.S., 1983, Retrospective study on complications and adverse effects of treatment with thrombin-like enzymes- a multicenter trial, Thrombos. Haemostas. 50, 604.
29. Laudano, A.P. and R.F. Doolittle, 1980, Studies on synthetic peptides that bind to fibrinogen and prevent fibrin polymerization. Structural requirements, number of binding sites, and species difference, Biochemistry 19, 1013.
30. Mahir, M.S., J.W. Hynd, P.T. Flute and J.A. Dormandy, 1987, Effect of defibrinogenation on the early patency rate of experimental small calibre arterial grafts, Br. J. Surg. 74, 508.
31. Martin, D.L., R.E. Hollinger, N. Suwanwela and E.J. Fedor, 1971, Experimental defibrination produced by ABBOTT-38414 (ancrod) and associated effects on some other factors of the hemostatic system, Fed. Proc. 30, 424.
32. Martinez, J., E. Rich and C. Barsigian, 1989, Transglutaminase-mediated cross-linking of fibrinogen by human umbilical vein endothelial cells, J. Biol. Chem. 264, 20502.
33. Montgomery, R.R., T.J. Kunicki, C. Taves, D. Pidard and M. Corcoran, 1983, Diagonosis of Bernard-Soulier syndrome and Glanzmann's thrombasthenia with a monoclonal assay on whole blood, J. Clin. Invest. 71, 385.
34. Nabel, E.G., 1991, Biology of the impaired endothelium, Am. J. Cardiol. 68, 6C.
35. 131I, J. Clin Invest. 45, 1202.
36. Ribes, J.A., C.W. Francis and D.D. Wagner, 1987, Fibrin induces release of von Willebrand factor from endothelial cells, J. Clin. Invest. 79, 117.
37. Schwartz, A. and D.J. Triggle, 1984, Cellular action of calcium blocking drugs, Annu. Rev. Med. 35, 325.
38. Siberman, S., M.B. Bernik, E.V. Potter and H.C. Kwaan, 1973, Effects of ancrod (Arvin) in mice: studies of plasma fibrinogen and fibrinolytic activity, Br. J. Haematol. 24, 101.
39. Silvka, S.R. and P.A. Insel, 1988, Phorbol ester and neomycin dissociate bradykinin receptor-mediated arachidonic acid release and polyphosphoinositide hydrolysis in Madin-Darby canine kidney cells, J. Biol. Chem. 263, 14640.
40. 3 and glycoprotein IIb-IIIa with fibrinogen, J. Biol. Chem. 265, 12267.
41. Sprandio, J.D., S.S. Shapiro, P. Thiagarajan and S. McCord, 1988, Cultured human umbilical vein endothelial cells contain a membrane glycoprotein immunologically related to platelet glycoprotein Ib, Blood 71, 234.
42. Tanaka, K. and K. Sueishi, 1993, Biology of disease: the coagulation and fibrinolysis systems and atherosclerosis, Lab. Invest. 69, 5.
43. Tranqui, L., A. Andrieux, G. Hudry-Clergeon, J.J. Ryckewaert, S. Serger, A. Chapel, M.H. Ginsberg, E.F. Plow and G. Marguerie, 1989, Differential structural requirements for fibrinogen binding to platelets and to endothelial cells, J. Cell Biol. 108, 2519.
44. Watanabe, K. and K. Tanaka, 1983, Influence of fibrin, fibrinogen and fibrinogen degradation products on cultured endothelial cells, Atherosclerosis 48, 57.
45. Weimar, B. and U. Delvos, 1986, The mechanism of fibrin-induced disorganization of cultured human endothelial cell monolayers, Arteriosclerosis 6, 139.
46. Weksler, B.B., C.W. Ley and E.A. Jaffe, 1978, Stimulation of endothelial cell prostacyclin production by thrombin, trypsin, and the ionophore A23187, J. Clin. Invest. 62, 923.